Evidence map›Paper›PMID 31102266›Full record

ArticleThe British journal of dermatology2019

Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.

J S Barbieri, J M Gelfand

Abstract readEvaluation StudyLetter
In one paragraph

Article in The British journal of dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J S BarbieriDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, U.S.A.ORCID 0000-0002-5467-4102
J M GelfandDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, U.S.A.

Funding

Penn Dermatology Research Training ProgramT32AR007465 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice, David Joel Margolis · 1986 to 2026
$9.0M
Study Design and Data AnalysisP30AR069589 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice · 2016 to 2026
$8.6M
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health T32-AR-007465NIAMS NIH HHS 1P30AR069589-01NIAMS NIH HHS P30 AR069589NIAMS NIH HHS T32 AR007465Pfizer FellowshipTrustees of the University of Pennsylvania
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Quality of LifeSeverity of Illness IndexCross-Sectional StudiesDermatologyHumansPsoriasisTreatment OutcomeUnited States

Identifiers

PMID31102266
PMCPMC7412621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.